Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Salmeterol (50mcg) + Fluticasone Propionate (250mcg)
Therapeutic Category
Asthma, Pulmonary, Respiratory
Dosage Form
aero Caps
Packaging Type
Capsule
Packaging
30
Price
₹492/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Flutialfa SF 250 Capsules combine two active ingredients, Salmeterol (50mcg) and Fluticasone Propionate (250mcg), designed to provide effective relief for individuals suffering from chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). This combination therapy targets both the inflammatory and bronchoconstrictive elements of respiratory disease, providing comprehensive management of symptoms.
Salmeterol is a long-acting beta-agonist (LABA) that helps relax the muscles around the airways, preventing bronchoconstriction and improving airflow. It works for up to 12 hours, making it ideal for long-term control of asthma and COPD symptoms.
Fluticasone Propionate is a potent corticosteroid that reduces inflammation in the airways, which helps prevent asthma attacks and reduces the frequency and severity of COPD exacerbations. By controlling inflammation, Fluticasone Propionate improves lung function and decreases the risk of flare-ups.
Common side effects of Flutialfa SF 250 Capsules may include headache, throat irritation, dry mouth, and cough. Serious side effects, although rare, may include allergic reactions, including rash, swelling, or difficulty breathing, increased heart rate, or muscle cramps. Long-term use may also increase the risk of oral thrush (fungal infection in the mouth) and voice hoarseness.
Flutialfa SF 250 Capsules are indicated for: Asthma: Used for the long-term management and prevention of asthma symptoms, including wheezing, shortness of breath, and chest tightness. Chronic Obstructive Pulmonary Disease (COPD): For the maintenance treatment of COPD to improve lung function and prevent exacerbations.
Do not exceed the prescribed dose and follow your healthcare provider’s instructions. Rinse your mouth after using the medication to reduce the risk of oral thrush. If you experience any severe side effects or signs of an allergic reaction, contact your healthcare provider immediately.
Store at room temperature, between 15°C to 30°C. Protect from moisture and sunlight. Keep the capsules in their original packaging and out of reach of children.
Composition : Salmeterol (25mcg) + Fluticasone Propionate (500mcg)
Composition : Salmeterol (25mcg) + Fluticasone Propionate (250mcg)
Composition : Ambroxol (10mg/5ml) + Guaifenesin (25mg/5ml) + Terbutaline (0.5mg/5ml)
Composition : Ambroxol (15mg/5ml) + Guaifenesin (50mg/5ml) + Menthol (2.5mg/5ml) + Terbutaline (1.25mg/5ml)
Composition : Chlorpheniramine Maleate (2mg/5ml) + Levodropropizine (30mg/5ml)
Composition : Acebrophylline (100mg) + Acetylcysteine (600mg)
Composition : Acebrophylline (200mg) tablet
Composition : Acebrophylline (200mg) + Desloratadine (5mg) + Montelukast (10mg) Tablet
Composition : Acetylcysteine (600mg) effervescent
Composition : Ambroxol (15mg) + Guaifenesin (50mg) + Phenylephrine (5mg) + Paracetamol (325mg) + Cetirizine (5mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Salmeterol 50mcg + Fluticasone Propionate 250mcg Rotacap has strong demand in the respiratory, pulmonology, and chronic care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on asthma and COPD management portfolios.
Medical distributors and agencies can benefit from consistent demand for long-term respiratory disease management under medical supervision. Salmeterol 50mcg is a long-acting beta-2 agonist (LABA) that helps keep airways open for extended periods Fluticasone Propionate 250mcg is an inhaled corticosteroid that helps reduce airway inflammation and prevent respiratory symptoms Commonly prescribed for bronchial asthma, chronic obstructive pulmonary disease (COPD), recurrent wheezing, and chronic inflammatory airway disorders Provides dual-action therapy through bronchodilation and inflammation control The Rotacap formulation ensures targeted drug delivery directly to the lungs for improved therapeutic outcomes Widely used by pulmonologists, chest physicians, and respiratory specialists This strengthens a comprehensive respiratory and chronic care portfolio
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Salmeterol 50mcg + Fluticasone Propionate 250mcg Rotacap with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong chronic therapy demand, repeat monthly prescriptions, growing respiratory disease management requirements, reliable supply chain support, and attractive margins in the respiratory care segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.